The international company specialised in pharma engineering has opened a new office in Bangalore, meaning its presence in India is over 500 people
Image credit: NNE
In April 2023, Denmark-based NNE opened a new office in Bangalore, India.
NNE is an international company specialised in pharma engineering reporting $281m in revenue in 2022. An increase of 34% from 2021, as per the company's latest financial report.
"Our new office in Bangalore, India is officially ready! The opening was not only a huge festive success, it also marked a big milestone: NNE in India is now 500+ people strong," the company stated.
"This new workspace not only gives us more space to grow, [and] it also creates a conducive environment for collaborating across our global offices. That means offering state-of-art amenities – and finding the best people," the company concluded.
In 1996, NNE (formerly known as NNE Pharmaplan) began its operations in India. The firm now has over 400 employees at its Bengaluru headquarters.
The regional office offers pharma and biotech customers the full range of NNE’s engineering and consulting services.
"Our experts always strive to serve our customers with state-of-the-art expertise and the latest technology know-how. We work in international teams together with our colleagues from Denmark and the US. In 2012, we decided to establish a Vaccine Centre of Competence in our Bengaluru office. Acting as a global coordination hub for NNE's vaccine projects, the centre draws together the company's experiences in India and other emerging economies."